Trials / Completed
CompletedNCT00986882
To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients
A Double-blind, Randomized, Single Dose, Placebo Controlled, Three Part Study to Evaluate the Safety and Tolerability, Efficacy and Dose Response of SAF312 in Postoperative Dental Pain Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 183 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The study will assess the analgesic efficacy and safety and tolerability of a single oral dose of SAF312 in postoperative dental pain patients after 3rd molar extraction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SAF312A | |
| DRUG | Placebo | |
| DRUG | Ibuprofen |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2009-09-30
- Last updated
- 2020-12-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT00986882. Inclusion in this directory is not an endorsement.